Top Stories
-
Source:
Mailman School of Public HealthLay Health Advisor programs have shown remarkable promise in addressing health inequities, and some of the structural barriers to health, experienced by Black women.
Topic
-
After being diagnosed in 2001 with chronic lymphocytic leukemia and again in 2018 with lung cancer, Mary Ann is now successfully managing her disease and returning to her calling as an actress.
Topic
-
A new study reveals that Black and Hispanic cancer patients, following a COVID-19 diagnosis, are suffering from greater treatment delays or discontinuations altogether.
Topic
-
Source:
CUIMC NewsroomA study, led by Benjamin Izar, MD, is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, and provides leads to why severe cases of COVID-19 experience long-term complications.
Topic
Latest News
-
Source:
Columbia NewsMarch 30, 2021Kenneth Olive shares what it was like and lessons learned from jumping into relief efforts during the start of the COVID-19 pandemic.
Topic
- March 11, 2021
Congratulations to Dr. Scuoppo who has been awarded an ASH Restart Award to support his ongoing research in novel therapeutics for diffuse large B-cell lymphoma.
Topic
- February 3, 2021
Data from a new retrospective study finds that patients undergoing active chemotherapy were not at an increased risk of getting COVID-19.
Topic
- February 2, 2021
Faculty and staff of the HICCC answer the call to volunteer at the Armory--a major COVID-19 vaccination site at NYP and CUIMC. They share what motivated them to get involved!
Topic
- January 29, 2021
HICCC signs open letter, with more than 75 other leading cancer organizations, that urges patients to resume their cancer treatment and schedule their cancer screenings during the COVID-19 pandemic.
- January 5, 2021
In December 2020, the United States FDA authorized two approved COVID-19 vaccines. HICCC Deputy Director Gary Schwartz, MD, addresses what patients with cancer should know about the new vaccines.
- December 12, 2020
A new study by researchers in medicine and in systems biology is investigating the airway epithelium, or lining, of the lungs, to investigate potential druggable targets for COVID-19.
-
Source:
Columbia NewsSeptember 15, 2020Anil K. Rustgi shares his thoughts on how COVID-19 has shown that coordinating efforts across all aspects of science are vital to the success of our fight against this infectious disease.
- August 16, 2020
A large observational study in Cancer Discovery examined the association of COVID-19 treatments with 30-day all-cause mortality, as well as sociodemographic factors associated with treatment.
- June 30, 2020
There was little known at the time about COVID-19, particularly across patients with different underlying conditions like cancer. What was undeniable was its spread and devastating health effects.
Topic
